 42 PM / in 6 minutes BRIEF-Leap Therapeutics Announces First Patient Dosed With TRX518 Combination Therapy Reuters Staff 1 Min Read 
Jan 16 (Reuters) - Leap Therapeutics Inc: 
* LEAP THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED WITH TRX518 COMBINATION THERAPY IN ADVANCED SOLID TUMORS TRIAL Source text for Eikon: Further company coverage: